Publications by authors named "Lee D Cranmer"

Claim this Profile
B
Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
J Sybil Biermann, Angela Hirbe, Shivani Ahlawat, Nicholas M Bernthal, Odion Binitie, Lee D Cranmer

J Natl Compr Canc Netw· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic Targets.
Michael J Wagner, Erica M Pimenta, Nathan W Sweeney, Elizabeth T Loggers, Jesse L Roberts, Lee D Cranmer

JCO Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B7-H3 is widely expressed in soft tissue sarcomas.
Meghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, Borislav A Alexiev, Eleanor Y Chen, Lee D Cranmer

BMC Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Germline and Mosaic SDHA Mutation Is Associated With a Multicancer Syndrome Including Neuroblastoma, Renal Cancer, and Multifocal GI Tumor.
Lee D Cranmer, Eric Q Konnick, Jennifer R Yoshida, Angela L Jacobson, Bilal A Malik

JCO Precis Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020.
Michael J Wagner, Vinod Ravi, Stephanie K Schaub, Ed Y Kim, Jeremy Sharib, Lee D Cranmer

JAMA Netw Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Bonny Chau, Elizabeth T Loggers, Lee D Cranmer, Harveshp Mogal, Jeremy M Sharib

Am J Clin Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial.
Yongwoo David Seo, Hailing Lu, Graeme Black, Kimberly Smythe, Yuexin Yu, Lee D Cranmer

JAMA Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, demographics, and survival of malignant hemangioendothelioma in the United States.
Kelly G Paulson, Vinod Ravi, Brian P Rubin, Min Park, Elizabeth T Loggers, Lee D Cranmer

Cancer Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406).
Lee D Cranmer, Yao Lu, Rachel S Heise, Karla V Ballman, Elizabeth T Loggers

Clin Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib.
Cass G G Sunga, Michael S Higgins, Robert W Ricciotti, Yajuan J Liu, Lee D Cranmer

Cancer Rep (Hoboken)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac events among patients with sarcoma treated with doxorubicin by method of infusion: A real-world database study.
Lee D Cranmer, Lisa M Hess, Tomoko Sugihara, Howard G Muntz

Cancer Rep (Hoboken)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial Solitary Fibrous Tumor/Hemangiopericytoma Treated with Microsurgical Resection: Retrospective Cohort Analysis of a Single-Center Experience.
Shreya Swaminathan, Jacob Ruzevick, Vyshak Venur, Lia M Halasz, Jason Rockhill, Lee D Cranmer

Ther Clin Risk Manag· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
Michael J Wagner, Yuzheng Zhang, Lee D Cranmer, Elizabeth T Loggers, Graeme Black

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial.
Robin L Jones, Vinod Ravi, Andrew S Brohl, Sant Chawla, Kristen N Ganjoo, Lee D Cranmer

JAMA Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.
Lee D Cranmer, Bonny Chau, Jose G Mantilla, Elizabeth T Loggers, Seth M Pollack

Clin Orthop Relat Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells.
Peter H Goff, Laura Riolobos, Bonnie J LaFleur, Matthew B Spraker, Y David Seo, Lee D Cranmer

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients.
Brett A Schroeder, Yuzheng Zhang, Kimberly S Smythe, Parth Desai, Anish Thomas, Lee D Cranmer

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors.
Kristina M Wakeman, Qian S Zhang, Anshu Bandhlish, Lee D Cranmer, Robert W Ricciotti

Am J Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.
Merve Hasanov, Denái R Milton, William H Sharfman, Bret Taback, Lee D Cranmer

Oncoimmunology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes.
Brett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, Rachel M Gittelman, Marissa Vignali, Lee D Cranmer

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report.
Ali McBride, Andrew J Garcia, Lauren J Sanders, Kelly Yiu, Lee D Cranmer

J Med Case Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy.
Karan Kohli, Lu Yao, Theodore Scott Nowicki, Shihong Zhang, Ralph Graeme Black, Lee D Cranmer

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis.
Michael J Wagner, Seth M Pollack, Lee D Cranmer, Matthew J Thompson, Shannon Maxwell

Cancer Invest· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma-Reply.
Michael J Wagner, Lee D Cranmer, Seth M Pollack

JAMA Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical Trial.
Seth M Pollack, Mary W Redman, Kelsey K Baker, Michael J Wagner, Brett A Schroeder, Lee D Cranmer

JAMA Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis